OR25-5 Adverse Cardiovascular Events and Cause Mortality in Men During Testosterone Treatment: Individual Patient and Aggregate Data Meta-Analyses

BACKGROUND: The cardiovascular safety of testosterone treatment in low testosterone is widely acknowledged to be unclear. Testosterone increases haematocrit, thereby potentially increasing venous thromboembolism risk. The FDA lists cardiovascular risk and stroke as adverse effects of testosterone. S...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Marianne, Antonic, Kristina, Aucott, Lorna, Bhasin, Shalender, Bhattacharya, Siladitya, Brazzelli, Miriam, Cruickshank, Moira, Dhillo, Waljit, Ellenberg, Susan, Emmelot-Vonk, Marielle, Gianatti, Emily, Giltay, Erik, Grossmann, Mathis, Hackett, Geoff, Hildreth, Kerry, Hudson, Jemma, Marks, Leonard, Quinton, Richard, Snyder, Peter, Svartberg, Johan, Tan, Hui, Tenover, Lisa, Travison, Thomas, Wu, Frederick, Jayasena, Channa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627540/
http://dx.doi.org/10.1210/jendso/bvac150.1414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627540/
http://dx.doi.org/10.1210/jendso/bvac150.1414

Ejemplares similares